(11) 98705-3426
TrademarkIQ íconeTrademarkIQ
Voltar para busca
Dado oficial do USPTO

M MENARINI PILLS OF INNOVATION

Sabia que essa marca já está registrada no Estados Unidos?

Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.

Active USPTO registrationTipo: MistaEscritório: US

Snapshot rápido

M MENARINI PILLS OF INNOVATION

ST13

US500000079326472

Classe

5, 9, 16, 41, 42

Pedido

79326472

Registro

7051060

Diagnóstico de risco e oportunidade

Leitura executiva para decisão de naming, protocolo e monitoramento.

Atenção: há risco ativo

Situação USPTO

Active USPTO registration

Tipo de processo

Pedido e registro

Eventos registrados

42

Atualização mais recente

01/08/2026

Classificação

Registrada

Tipo de marca

Mista

Classes Nice

5, 9, 16, 41, 42

Data de depósito

19/04/2021

Data de registro

16/05/2023

Data de expiração

-

Ação recomendada

Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.

Próximo passo

Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.

Dados completos do processo

Campos estruturados da autoridade responsável e do histórico oficial.

Data da situação

16/05/2023

Última transação

01/08/2026

Escritório responsável

United States Patent and Trademark Office

Código da situação

700

Cadastro oficial

Principal Register

Código do desenho

3

Tipo de titular

16

Localização do titular

IT

Examinador

MCCAULEY, BRENDAN D

Unidade examinadora

M50

Localização atual

PUBLICATION AND ISSUE SECTION

Descrição da marca

The mark consists of an uppercase stylized letter "M" outlined in black on a square outlined in black, the interior of the letter is white, the two right triangles formed by the bottom of the "M" are the color red outlined in black, and the large isosceles triangle formed at the top of the letter "M" is black and is bisected from bottom to top by the stylized name "MENARINI" in white. On the right side of the letter "M" are the stylized words "PILLS OF" in black with the stylized light blue word "INNOVATION" underneath.

Titulares e representantes

Titulares

A. MENARINI INDUSTRIE FARMACEUTICHE RIUNITE S.r.l.

Representantes

Arthur DeBaugh Allman Spry Leggett Crumpler & Horn, P.A.

Classificação técnica

Classes Nice

Classe 5Classe 9Classe 16Classe 41Classe 42

Códigos Vienna

Sem códigos Vienna disponíveis.

Produtos e serviços

Classe 5

Antibiotics; anti-cancer preparations; pharmaceutical preparations for the treatment of inflammatory disorders; medicated preparations for skin treatment; pharmaceutical preparations for treating skin disorders

Classe 9

Blank magnetic data carriers; recording discsblank compact discsblank audio discsblank computer discs; recording discsaudio discs and compact discs featuring information on research and development in the pharmaceutical and biotechnology fields; DVDs featuring information on research and development in the pharmaceutical and biotechnology fields; blank compact discs; digital recording mediapre-recorded video cassettesdigital video discsdigital versatile discsdownloadable audio and video recordingsDVDshigh definition digital discs featuring information on research and development in the pharmaceutical and biotechnology fields; downloadable computer software for editing cinematographic film and for creating videos; apparatus for editing cinematographic film; electronic downloadable publicationsnewsletters and magazines in the field of medicine; camcorders; photographic cameras; cinematographic films featuring information on medicine; musical sound recordings; musical video recordings; blank USB flash drives

Classe 16

Paper; paper stationery; printed materialsbooksmagazinesprinted matter in the nature of printed bookletscataloguesprinted publications in the nature of newsletters and brochures and pamphlets in the fields of pharmaceutical drugsmedicine and art; stationery; writing stationery; cardboard boxes; conical paper bags; printed postcards; printed advertising posters; printed mounted posters; printed photographs; placards of paper; placards of cardboard; signboards of paper; printed calendars; printed almanacs; copyholders; paperweights; pencil holders; pens; writing or drawing books; printed diaries

Classe 41

Education servicesarranging and conducting of seminarsconferences and conventions in the fields of pharmaceutical drugsartmedicine; organization of educationalentertainmentsportingcultural eventsevents in the fields of pharmaceutical drugsartmedicine for cultural or educational purposes; digital videoaudiomultimedia publishing services; organization of cultural activities in the fields of pharmaceutical drugsmedicineart; production of radio and television entertainment services; audio recording and video productionphotography; production of television programs

Classe 42

Pharmaceutical research services; scientific research; genetic research; medical research; biological research; biotechnology research; laboratory research services relating to pharmaceuticals; research services relating to pharmaceuticals; scientific research services; biomedical research services; bacteriological research and analysis; stem cell research services; research and development of vaccines and medicines; research and development in the pharmaceutical and biotechnology fields

Publicações

Histórico de despachos e eventos da marca no USPTO.

42 publicações encontradas

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

31/07/2026

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

31/07/2026

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

31/07/2026

FINO

FINAL DECISION TRANSACTION PROCESSED BY IB

03/10/2023

XXSS

GENERIC MADRID TRANSACTION SENT TO IB

18/08/2023

XXCR

GENERIC MADRID TRANSACTION CREATED

18/08/2023

FICR

FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB

16/08/2023

NRCC

NOTICE OF REGISTRATION CONFIRMATION EMAILED

16/05/2023

OPNX

NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB

16/05/2023

R.PR

REGISTERED-PRINCIPAL REGISTER

16/05/2023

OPNS

NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB

26/04/2023

OPNR

NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB

26/04/2023

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

28/02/2023

PUBO

PUBLISHED FOR OPPOSITION

28/02/2023

GPNX

NOTIFICATION PROCESSED BY IB

27/02/2023

OPNS

NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB

08/02/2023

OP2R

NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB

08/02/2023

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

08/02/2023

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

25/01/2023

XAEC

EXAMINER'S AMENDMENT ENTERED

25/01/2023

GNEN

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

25/01/2023

GNEA

EXAMINERS AMENDMENT E-MAILED

25/01/2023

CNEA

EXAMINERS AMENDMENT -WRITTEN

25/01/2023

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

24/01/2023

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

24/01/2023

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

24/01/2023

GNFN

NOTIFICATION OF FINAL REFUSAL EMAILED

25/07/2022

GNFR

FINAL REFUSAL E-MAILED

25/07/2022

CNFR

FINAL REFUSAL WRITTEN

25/07/2022

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

27/06/2022

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

25/06/2022

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

25/06/2022

RFNT

REFUSAL PROCESSED BY IB

30/01/2022

RFCS

NON-FINAL ACTION MAILED - REFUSAL SENT TO IB

10/01/2022

RFRR

REFUSAL PROCESSED BY MPU

10/01/2022

RFCR

NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW

16/12/2021

CNRT

NON-FINAL ACTION WRITTEN

15/12/2021

MAFR

APPLICATION FILING RECEIPT MAILED

14/12/2021

DOCK

ASSIGNED TO EXAMINER

13/12/2021

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

08/12/2021

LIMI

LIMITATION FROM ORIGINAL APPLICATION ENTERED

07/12/2021

REPR

SN ASSIGNED FOR SECT 66A APPL FROM IB

25/11/2021

Proteção contínua da sua marca

Seja avisado a cada novo depósito que ameace M MENARINI PILLS OF INNOVATION ou a sua marca.

Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.